Feb 28, 2022 09:00AM

Nov 12, 2021 07:03AM

Nov 12, 2021 07:00AM

Nov 12, 2021 07:00AM

Nov 8, 2021 04:15PM

Nov 8, 2021 04:15PM

Oct 1, 2021 08:07AM Rubius Therapeutics (RUBY) Announces Preclinical Data for RTX-224, a Broad Immune Costimulatory Agonist, to be Presented at the Society for Immunotherapy of Cancer’s Annual Meeting

Oct 1, 2021 08:00AM

Oct 1, 2021 08:00AM

Jun 14, 2021 07:52PM

Mar 16, 2021 09:30AM

Nov 9, 2020 08:05AM

Nov 9, 2020 08:05AM

Mar 12, 2020 07:00AM Rubius Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results and Announces Strategic Focus on Oncology and Autoimmunity

Mar 12, 2020 07:00AM

Jan 13, 2020 08:18AM

Jan 13, 2020 08:00AM

Jan 13, 2020 08:00AM

Nov 19, 2019 04:30PM

Nov 8, 2019 07:00AM

Oct 2, 2019 07:00AM Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer

May 15, 2019 08:00AM

May 15, 2019 08:00AM

Mar 28, 2019 08:00AM

Mar 28, 2019 08:00AM

Mar 11, 2019 08:07AM

Mar 11, 2019 08:00AM

Mar 11, 2019 04:00AM Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria

Jan 7, 2019 08:06AM

Jan 7, 2019 08:00AM

Jan 7, 2019 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All